Evidence map›Paper›PMID 42745958›Full record

ArticleChina CDC weekly2026

Research Progress on Biomarkers Associated with Cervical Cancer Caused by HPV Infection.

Ci Wang, Peng Li, Junling Wang

Abstract read
In one paragraph

Article in China CDC weekly, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ci WangSchool of Public Health, Lanzhou University, Lanzhou City, Gansu Province, China.
Peng LiSchool of Public Health, Lanzhou University, Lanzhou City, Gansu Province, China.
Junling WangSchool of Public Health, Lanzhou University, Lanzhou City, Gansu Province, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cervical cancer(CC), a major global health burden for women, is closely associated with persistent infection with high-risk human papillomavirus (HR-HPV). Biomarker research is crucial for the precise prevention, early diagnosis, risk stratification, and treatment monitoring of cervical cancer. This article systematically reviews virus-derived, protein, epigenetic, and tumor microenvironment-related biomarkers associated with HPV-induced cervical cancer. By evaluating their diagnostic and prognostic value, this review provides insights to further improve the early diagnosis of cervical lesions.

Indexed as

BiomarkersCervical CancerHPV Infection

Identifiers

PMID42745958
PMCPMC13575576

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.